27449508|t|Modulation of Interleukins in Sepsis - Associated Clotting Disorders: Interplay With Hemostatic Derangement
27449508|a|Interleukins play a central role in the immune system and are involved in a variety of immunological, inflammatory, and infectious disease states including sepsis syndrome. Levels of interleukins may correlate with overall survival and may directly or indirectly affect some of the regulators of coagulation and fibrinolysis, thereby disrupting hemostasis and thrombosis. Our hypothesis is that in sepsis-associated coagulopathies (SACs), interleukins may be upregulated, leading to hemostatic imbalance by generating thrombogenic mediators. We profiled the levels of interleukins IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10 in addition to d-dimer (DD) in patients with SAC and in normal donors. We observed the highest increase in interleukins IL-6 (322-fold), IL-8 (48-fold), IL-10 (72-fold), and DD (18-fold). This suggests that interleukins such as IL-6 and IL-10 have a close association with coagulopathy and fibrinolytic dysregulation in sepsis and can be considered as candidates for potential therapeutic targets in SAC.
27449508	0	10	Modulation	T082	C0443264
27449508	14	26	Interleukins	T116,T129	C0021764
27449508	30	36	Sepsis	T047	C0036690
27449508	39	49	Associated	T080	C0332281
27449508	50	68	Clotting Disorders	T047	C0005779
27449508	85	107	Hemostatic Derangement	T047	C0005779
27449508	108	120	Interleukins	T116,T129	C0021764
27449508	128	135	central	T082	C0205099
27449508	136	140	role	T077	C1705810
27449508	148	161	immune system	T022	C0020962
27449508	170	178	involved	T169	C1314939
27449508	195	208	immunological	T047	C0021053
27449508	210	222	inflammatory	T047	C1290884
27449508	228	246	infectious disease	T047	C0009450
27449508	247	253	states	T169	C1442792
27449508	264	279	sepsis syndrome	T047	C0036690
27449508	281	287	Levels	T080	C0441889
27449508	291	303	interleukins	T116,T129	C0021764
27449508	308	317	correlate	T080	C1707520
27449508	323	339	overall survival	T081	C4086681
27449508	348	356	directly	T080	C1947931
27449508	360	370	indirectly	T080	C0439852
27449508	371	377	affect	T041	C0001721
27449508	390	400	regulators	T121,T129	C0005525
27449508	404	415	coagulation	T042	C0005778
27449508	420	432	fibrinolysis	T039	C0016017
27449508	453	463	hemostasis	T042	C0019116
27449508	468	478	thrombosis	T046	C0040053
27449508	484	494	hypothesis	T078	C1512571
27449508	506	538	sepsis-associated coagulopathies	T047	C0005779
27449508	540	544	SACs	T047	C0005779
27449508	547	559	interleukins	T116,T129	C0021764
27449508	567	578	upregulated	T044	C0041904
27449508	591	611	hemostatic imbalance	T047	C0005779
27449508	626	648	thrombogenic mediators	T123	C0574031
27449508	653	661	profiled	T169	C2003903
27449508	666	672	levels	T080	C0441889
27449508	676	688	interleukins	T116,T129	C0021764
27449508	689	694	IL-1α	T116,T123	C0600251
27449508	696	701	IL-1β	T116,T129	C0021753
27449508	703	707	IL-2	T116,T129	C0021756
27449508	709	713	IL-4	T116,T129	C0021758
27449508	715	719	IL-6	T116,T129	C0021760
27449508	721	725	IL-8	T116,T129	C0079633
27449508	731	736	IL-10	T116,T129	C0085295
27449508	737	751	in addition to	T169	C0332287
27449508	752	759	d-dimer	T116,T123	C0060323
27449508	761	763	DD	T116,T123	C0060323
27449508	768	776	patients	T101	C0030705
27449508	782	785	SAC	T047	C0005779
27449508	793	799	normal	T080	C0205307
27449508	800	806	donors	T098	C0005795
27449508	811	819	observed	T169	C1441672
27449508	824	831	highest	T080	C1522410
27449508	832	840	increase	T169	C0442805
27449508	844	856	interleukins	T116,T129	C0021764
27449508	857	861	IL-6	T116,T129	C0021760
27449508	863	871	322-fold	T081	C1880833
27449508	874	878	IL-8	T116,T129	C0079633
27449508	880	887	48-fold	T081	C1880833
27449508	890	895	IL-10	T116,T129	C0085295
27449508	897	904	72-fold	T081	C1880833
27449508	911	913	DD	T116,T123	C0060323
27449508	915	922	18-fold	T081	C1880833
27449508	930	938	suggests	T078	C1705535
27449508	944	956	interleukins	T116,T129	C0021764
27449508	965	969	IL-6	T116,T129	C0021760
27449508	974	979	IL-10	T116,T129	C0085295
27449508	993	1009	association with	T080	C0332281
27449508	1010	1022	coagulopathy	T047	C0005779
27449508	1027	1053	fibrinolytic dysregulation	UnknownType	C0543673
27449508	1057	1063	sepsis	T047	C0036690
27449508	1075	1085	considered	T078	C0750591
27449508	1089	1099	candidates	T116,T129	C0021764
27449508	1104	1113	potential	T080	C3245505
27449508	1114	1125	therapeutic	T169	C0302350
27449508	1126	1133	targets	T169	C1521840
27449508	1137	1140	SAC	T047	C0005779